What is a Compassionate Use Program?
Compassionate use is a term used to describe the provision of an unauthorized medicine when it is given to a patient at no cost. This usually occurs when a drug company recognizes there is [...]
We are a Pharmaceutical Services Provider that specializes in Drug Development Programs, Treatment Access Solutions and Market Access and Commercialization
We are experienced in Phase I – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.
We are experienced in Phase I – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.
Industry leader with over 16 years of experience designing and deliveing calue-driven Expanded Access (EAPs) and Post-Trial Access Programs.
Compassionate use is a term used to describe the provision of an unauthorized medicine when it is given to a patient at no cost. This usually occurs when a drug company recognizes there is [...]
Compassionate use refers to the use of an unapproved drug to treat a patient, outside of a clinical trial setting, when no other viable treatment options are available. Compassionate use can also be referred to [...]